SARS-CoV-2 Spike Protein RBD (E484K Mutation)
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Spike Protein Receptor-Binding Domain (RBD) is a recombinant protein expressed in Mammalian cells.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
The E484K mutation is present in several variants, including those first identified in South Africa and Brazil. This mutation has been reported to reduce antibody neutralization of the virus.
The SARS-CoV-2 Spike Protein (S protein) is a viral protein that allows the entry of SARS-CoV-2 into human cells. The protein forms trimers on the viral capsid and binds to human Angiotensin Converting Enzyme 2 (ACE2) located on the cell surface. The protein has a cleavage site between the Spike Protein and S2 subunits that is targeted by the human enzyme Furin, and it may also cause the development of a syncytium (cell fusion). Antibodies to S protein can prevent viral entry as well as target the virus for further immune action.
The E484K mutation is present in several variants, including those first identified in South Africa and Brazil. This mutation has been reported to reduce antibody neutralization of the virus.
| Supplier | Abbexa Ltd. |
|---|---|
| Product # | abx620005-1MG |
| Pricing | 1 mg USD $1972.0 |
| Conjugation | Unconjugated |
| Host | Mammalian cells |
| Tested Applications | SDS-PAGE |
| Dry Ice | No |
| Availability | Shipped within 5-10 working days. |
| Note |
|